Free Trial

Phathom Pharmaceuticals (PHAT) SEC Filings & 10K Form

Phathom Pharmaceuticals logo
$10.94 +0.32 (+2.96%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Phathom Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/20/2025
4:18 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
08/07/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/24/2025
4:00 PM
Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2025
4:00 PM
Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
9:47 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
06/06/2025
12:29 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
06/05/2025
3:54 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:56 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:56 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:58 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:58 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:30 PM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/23/2025
3:06 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
4:17 PM
Breedlove Robert Charles (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:22 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
05/08/2025
4:27 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
1:30 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:03 PM
Phathom Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
3:05 PM
Phathom Pharmaceuticals (Filer)
Form DEFA14A
04/16/2025
4:37 PM
Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2025
4:44 PM
Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
4:29 PM
Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
4:30 PM
Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
4:08 PM
Phathom Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/01/2025
7:17 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:46 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:27 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:18 PM
Phathom Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:24 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:20 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:05 AM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
12/16/2024
7:05 AM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
10:46 AM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:12 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
11/05/2024
2:32 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G
11/04/2024
10:20 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
08/22/2024
3:05 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHAT) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners